Company Overview

Development Stage

About the Company

上海复宏汉霖生物制药有限公司成立于2014年06月26日,主要经营范围为生物科技(除转基因生物、人体干细胞基因诊断)领域内技术开发、技术服务、技术转让、技术咨询,化学试剂(除医疗诊断试剂)、仪器仪表的销售,从事货物及技术进出口业务等。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

Recruitment Overview / Current Status (30 open positions)

Manage
Note: How fast is hiring at 上海复宏汉霖生物制药有限公司 growing? 2026: 42 openings, 2025: 38 openings, 2022: 5 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

Master's Degree Job Demand Analysis

(More)
N/A
Growth Rate
Master's Hiring by Year: 2026
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 上海复宏汉霖生物制药有限公司 growing? Master's recruitment over the years: 2026: 1 openings, 2022: 3 openings.

R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 上海复宏汉霖生物制药有限公司? Based on an analysis of 's job postings over the past year, "生物/制药/化工/环保类" demand: 19.4%, "医疗卫生/美容保健类": 9%, "美术/设计/创意类": 1.5%, "计算机/网络/技术类": 1.5%. For reference only.

— What Are the Salaries Like? (67 records)

Manage
salary range: 3K - 30K, 61.1% of roles pay ¥10-20K
Note: salary statistics are based on 67 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 上海复宏汉霖生物制药有限公司?61.1% of positions earn 10-20K, Fresh graduate salary: ¥5.3K。销售类 average salary ¥14.3K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of

(More)
Are salaries high at 上海复宏汉霖生物制药有限公司? We provide: 医药代表,生物制药,实习生,客户经理,qc,仓库,信息,分析,学术主管,销售,临床,地区经理,学术专员,库管,系统主管,细胞培养,药学,配液技术员,供应链,制剂技术员. Click to view detailed salary analysis by job.

honors, qualifications & industry associations

Tags are labelled based on keyword text matching analysis and may be related to the company. For reference only.

Related Industry Tags

Job Category

  • 销售类
    61.2% of total 61.2%
  • 工厂生产类
    22.4% of total 22.4%
  • 生物/制药/化工/环保类
    19.4% of total 19.4%
  • 经营管理类
    16.4% of total 16.4%

Education

  • 本科
    46.3% of total 46.3%
  • 大专
    46.3% of total 46.3%
  • 不限
    4.5% of total 4.5%
  • 高中
    1.5% of total 1.5%

Experience

  • 不限
    47.8% of total 47.8%
  • 1-3年
    31.3% of total 31.3%
  • 5-10年
    13.4% of total 13.4%
  • 3-5年
    6% of total 6%
View Detailed Analysis

What does 上海复宏汉霖生物制药有限公司 require? Who is 上海复宏汉霖生物制药有限公司 hiring? recruitment: 销售类占比最多占61.2%,其次是工厂生产类占22.4%. What education can get in at ? 本科占比最多占46.3%,其次是大专占46.3%. High education required at ? 硕士占1.5%. Work experience required at ? 不限占比最多占47.8%,其次是1-3年占31.3%. Where are the job locations at ? 上海占比最多占44.8%,其次是无锡占4.5%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 74,000万(元)
Legal Representative: 朱俊
Date Established:
Credit Code: 913101043987290369
Registered Address: 上海市徐汇区宜山路1289号1幢(D楼)全幢

Partners & Suppliers

复宏汉霖授予欧加隆在全球除中国、欧洲、美国外的市场商业化汉利康、汉曲优等多款产品的权利 Source
合作客户 海外商业化授权
复宏汉霖与上海生物制品研究所合作开发抗新冠病毒中和抗体 Source
供应商 研发合作
复宏汉霖授权奥赛康在中国大陆独家推广汉曲优(曲妥珠单抗) Source
合作客户 中国区推广合作
复宏汉霖采购通用电气医疗的一次性生物反应器等生物工艺设备 Source
供应商 生物工艺设备
复宏汉霖与默克在细胞培养基和工艺开发方面合作 Source
供应商 工艺与培养基

People who follow this company also follow

Competitors (Similar Companies)

“Research and development and industrialization of monoclonal antibody ”
“Steroid APIs and preparations. Produce first-class products, committed”
制药/药业 抗肿瘤药 原料药 肿瘤药物
“Beauty for all”
“A technology-driven international pharmaceutical enterprise”
机械设备 生产 制造 检测设备
“To develop high-quality biologics that are accessible and affordable f”
“Making the world's good life within reach”
“致力于创新生物药物研发的高科技公司”
“做好人,做好药”
“Global integrated biopharmaceutical enterprise”
科学研究 创新服务 研究院/研究所
制药/药业 医药 医药中间体 仿制药
“Committed to patient health, providing internationally qualified medic”
“In the rapidly growing biopharmaceutical field, accelerate and transfo”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates